Pharmaceuticals Market Research Reports & Consulting

discount on Mnm

Market Reports

Title Published Price TOC Available

Bleeding Disorders Treatment Market by Type (Hemophilia A, Hemophilia B, vWD), Drug Class (Plasma Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antibrinolytics, Fibrin Sealant) - Global Forecast to 2021

The global bleeding disorders treatment market is expected to reach USD 15.09 Billion by 2021 from USD 10.33 Billion in 2016 at a CAGR of 7.9% from 2016 to 2021. The major factors driving the market growth include the growing patient population base, R&D activities, and increasing focus on recombinant products by pharmaceutical companies. Emerging markets offer significant growth opportunities for the bleeding disorders treatment market.

July 2016 $ 5650 selected

Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, Binder, Lubricant, Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021

The global pharmaceutical excipients market is projected to reach USD 8.1 Billion in 2021 at a CAGR of 6.1% in the forecast period 2016 to 2021. The rising demand for newer & improved drugs, development of new drug delivery systems, and greater understanding of the functional benefits of excipients are positively impacting the overall growth of the market.

June 2016 $ 5650 selected

Superdisintegrants Market by Product (Croscarmellose Sodium, Crospovidone, Sodium Starch Glycolate, Ion Exchange Resins), Application (Tablets, Capsules), Therapeutic Area (Oncology, Neurology, Cardiology, Infectious Diseases) - Global Forecast to 2021

The global superdisintegrants market is expected to reach USD 416.5 Million by 2021 from USD 286.8 Million in 2016, at a CAGR of 7.8% during the forecast period of 2016 to 2021. Growing generic drugs market, growing population of geriatric and paediatric patients, and emergence of new superdisintegrants for the pharmaceutical industry are factors driving the growth of the superdisintegrants market. However, factors such as declining R&D expenditures in the development of new superdisintegrants may restrain the growth of this market during the forecast period.

June 2016 $ 5650 selected

Sunitinib Malate Market Forecast for Pancreatic Cancer, 2016-2017, G7 Countries, (U.S., Germany, France, U.K., Italy, Spain, Japan)

The sunitinib malate market for pancreatic cancer is projected to reach USD 76.7 Million by 2021, at a CAGR of 13.9% from 2016 to 2021. Over the years, the sunitinib malate market for pancreatic cancer has observed steady growth and this trend is expected to continue in the coming years. This is primarily because the market is witnessing increasing adoption of drug therapy for the treatment of pancreatic cancer. This report categorizes patients with pancreatic neuroendocrine tumors (pNET) based on three different stages, namely, localized, advanced, and distant.

May 2016 $ 5650 selected

Empty Capsules Market by Product (Gelatin (Porcine, Bovine, Bone Meal), Non-Gelatin (HPMC, Pullulan)), Application (Antibiotics, Vitamins, Anti-Inflammatory, Ant anemic) & End User (Pharmaceutical, Nutraceutical, Cosmetics) - Global Forecast to 2021

The empty capsules market is expected to witness significant growth in the coming years owing mainly to factors such as the rapidly increasing geriatric population, technological innovations, growing applications in the pharmaceutical industry, and the rapidly expanding nutraceutical industry. The global empty capsules market is projected to reach USD 2.13 Billion by 2021 from USD 1.5 Billion in 2016, at a CAGR of 7.2% from 2016 to 2021. However, factors such as rising prices and cultural and religious practices limit the growth of the gelatin capsules market, which in turn affects the growth of the empty capsules market.

May 2016 $ 5650 selected

Enteral Feeding Formulas Market by Product (Polymeric, Monomeric, Disease-Specific Formulas), by Stage (Adults, Pediatrics), by Application (Oncology, Gastroenterology, Neurology), by End User (Hospitals, LTCS, Home Care) - Global Forecast to 2020

The global enteral feeding formulas market is estimated to reach USD 5.95 Billion by 2020, growing at a CAGR of 7.6% during the forecast period. The enteral feeding formulas market is mainly driven by the rising incidences of chronic diseases and disorders, the rapidly increasing geriatric population, increasing healthcare expenditure, rising prevalence of preterm births, and increasing demand for homecare.

March 2016 $ 5650 selected

Animal Parasiticides Market by Product (Endoparasiticides, Ectoparasiticides, Endectocides, Oral Liquids, Tablets, Injectables, Sprays, Pour-on, Spot-on, Collars, Ear Tags) by Animal (Dogs, Cats, Cattle, Pigs, Sheep and Goats, Poultry) - Global Forecast to 2020

The global animal parasiticides market is estimated to grow at a CAGR of 5.7% from 2015 to 2020 to reach USD 9.75 Billion by 2020. Factors such as increasing awareness about animal healthcare, rising demand for animal-derived food products, growth in the adoption of companion animals, and rising concern to prevent zoonotic diseases are driving the growth of the animal parasiticides market. Rising veterinary practices, huge investments from government organizations and private players for R&D activities, and increase in the animal healthcare expenditure have further propelled the growth of the animal parasiticides market.

February 2016 $ 5650 selected

Pharmaceutical Packaging Equipment Market by Package Type (Blister, Strip, Bottle, Tube, Aseptic Packaging, Wrapping, Labeling & Serialization), by Product Type (Tablet, Powder, Cream, Syrup, Aseptic Liquid, Aerosol) - Global Forecast to 2020

The global pharmaceutical packaging equipment market is estimated to grow at a CAGR of 6.9% from 2015 to 2020 to reach USD 7.24 Billion by 2020. Growth in the generics market, the rising need for novel and flexible packaging equipment, growing offshore manufacturing of pharmaceutical packaging equipment, growth of contract manufacturing, and regulatory compliance mandating the replacement of old equipment are some major factors driving the growth of this market.

February 2016 $ 5650 selected

Immunotherapy Drugs Market by Type of Drug (Monoclonal Antibodies, Interferon-Alpha, Interleukins, Vaccines, (Therapeutic Vaccines and Preventive Vaccines), Checkpoint Inhibitors), Epidemiology, Regulatory and Pipeline Analysis - Global Forecast to 2020

The immunotherapy drugs market is estimated to grow at a CAGR of 12.8% to reach USD 73,529.2 Million by 2020. The checkpoint inhibitors, by type of drugs, are expected to witness the fastest growth during the forecast period. In this report, the immunotherapy market is segmented into types of drugs and region. By types of drug, the market is further subsegmented into antibodies, interferons, interleukins, vaccines and checkpoint inhibitors.

November 2015 $ 5650 selected

European Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)), Application (Oncology, Thyroid, Cardiology), Procedures - Forecasts to 2020

Over the years, the European nuclear medicine/radiopharmaceuticals market has witnessed various advancements in radiopharmaceuticals. The European radiopharmaceuticals market is witnessing growth owing to an increasing number of radioisotope approvals for different clinical indications. Tc-99m and F-18 radioisotopes are estimated to contribute the highest to the European nuclear medicine diagnostic market in 2015, whereas Ra-223, I-131 and Y-90 ensured their leading position in the therapeutic market. The European nuclear medicine/radiopharmaceuticals market is expected to reach $1.62 Billion by 2020 from $1.09 Billion in 2015, growing at a CAGR of 8.2% from 2015 to 2020.

November 2015 $ 5650 selected

Wellness Supplements Market by Product (Dietary Supplements (Vitamin, Mineral, Protein, Herbal), Functional/Fortified Food & Beverages, Food Intolerance (Gluten-Free, Lactose-Free), Dermo-Cosmetic Skin Essentials (Anti-Acne)) - Global Forecast to 2020

The global Wellness Supplements market is expected to reach USD 249.4 Billion by 2020 from USD 183.1 Billion in 2015, at a CAGR of 6.4% during the forecast period. The growth of wellness supplement is mainly driven by factors such as rising geriatric population, growing prevalence of chronic diseases, rising awareness about benefits of wellness supplements, rising healthcare costs, and shift of consumers from care to preventive. However, regulatory compliance is likely to restrain the growth of wellness supplement market to a certain extent.

November 2015 $ 5650 selected

Active Pharmaceutical Ingredient Market by type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech), Type of Manufacturer (Captive, Merchant), Therapy (Oncology, diabetes, Orthopedic, CNS, Nephrology, Ophthalmology) - Global Forecast to 2020

The global Active Pharmaceutical Ingredients Market is expected to reach USD 205.51 billion by 2020 from USD 150 billion in 2015, at a CAGR of 6.5% during the forecast period. Factors such as the increasing incidence of life style and age related diseases, Increasing prevalence of cancer across the world, Technological advancements in the APIs Manufacturing, Emerging markets for biosimilars and increasing scope for Highly potent active ingredients are driving market growth. On the other hand, stringent regulatory requirements and global economic recession may restrict market growth.

October 2015 $ 5650 selected

Clinical Trial Supplies Market by Products & Services (Logistics & Distribution, Manufacturing, Packaging and Labeling), Phases (Phase I, Phase II, Phase III) & Therapeutic Areas (CNS & Mental Disorders, Cardiovascular, Oncology) - Global Forecast to 2020

The global clinical trial supplies market is expected to reach USD 1,274.3 Million by 2020 from USD 904.3 Million in 2015, at a CAGR of 7.1%. The global clinical trial supplies market is broadly classified into manufacturing services, packaging and labeling services, and logistics and distribution services. The logistics and distribution segment is expected to account for the largest share of the global clinical trial supplies products market in 2015.

October 2015 $ 5650 selected

U.S. General Anesthesia Drugs Market by Molecule (Propofol, Benzodiazepines, ketamine(s(+) ketamine HCl), Methohexital Sodium), route of administration (Intravenous, Inhalational), Supply Chain (GPOs, Distributors), Competitive - Analysis Forecast to 2020

The U.S. general anesthesia drugs market is poised to reach ~USD 2.0 Billion by 2020 from USD 1.6 Billion in 2015, at a CAGR of 3.8% from 2015 to 2020. Factors such as rapid rise in aging population, rising prevalence of cardiovascular and respiratory system-related diseases, and rising number of emergency surgeries are key factors driving the growth of the U.S. general anesthesia drugs market. However, side effects associated with ketamine usage (such as elevation in blood pressure and heart rate, amnesia, respiratory depression, and hallucinations), regulatory issues, and lower compliance rates in comparison with other anesthetic drugs are likely to restrain the growth of this market.

July 2015 $ 5650 selected

Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2020

The nuclear medicine/radiopharmaceuticals market is segmented on the basis of type, application, and region. The global nuclear medicine/radiopharmaceuticals market is expected to reach $6.96 Billion by 2020 from $4.50 Billion in 2015, growing at a CAGR of 9.1% from 2015 to 2020. The market is dominated by North America, followed by Asia-Pacific, Europe, and the Rest of the World (RoW) regions. The Asia-Pacific region is expected to grow at the fastest rate during the forecast period.

July 2015 $ 5650 selected

Veterinary / Animal Vaccines Market by Product (Livestock, Companion, Poultry, Equine, Porcine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Swine& Avian Influenza, Strangles) & Technology (Live attenuated, DNA, Inactivated) - Global Forecast to 2020

The global veterinary vaccines market is poised to reach $7,197.9 Million by 2020 from $5,507.3 Million in 2015, at a CAGR of 5.5% from 2015 to 2020. Based on product type, the veterinary vaccine market is categorized into companion animal vaccines, livestock vaccine, poultry vaccines, porcine vaccines, equine vaccines, aquaculture vaccines, and other animal vaccines (including vaccines for deer, elephants, camels, bats, and rabbits). Among these, the companion animal vaccines segment is the fastest-growing segment due to increasing prevalence of zoonotic diseases in humans, and the growing pet population.

June 2015 $ 5650 selected

Weight Loss and Weight Management Market by Equipment (Fitness Equipment (Treadmill, Stair Steppers)), Surgical Equipment (Adjustable Gastric Band, Gastric Bypass), Diet (Weight Loss Meals, Diet Soft Drinks), Weight Loss Services - Forecast to 2019

The global weight loss and weight management market is expected to reach $206.4 billion by 2019 from $148.1 billion in 2014, growing at a CAGR of 6.9%. Major factors driving the growth of this market include increase in obese population, strong government support and funding, lifestyle changes, increase in membership for health clubs, and technological advancements. On the other hand, high cost of low-calorie diets and deceptive marketing strategies adopted by industry players are hindering the growth of this market.

February 2015 $ 5650 selected

Cleanroom Technology Market by Equipment (HVAC System, HEPA Filter, Air Shower, Air Diffuser), Consumables (Apparel, Gloves, Wipes, Disinfectants), Construction (Hardwall, Softwall), & by End User (Pharmaceutical, Biotech) – Global Forecast to 2019

Over the years, the demand for cleanrooms for healthcare industry has increased significantly owing to the stringent healthcare regulations, emergence of biologics, growing pharmaceutical industry, and rising application of cleanrooms in medical device industry. Further, the growing healthcare industry in the developing regions such as China and India would provide extensive growth opportunities for the cleanroom technology market. However, high cost associated with installation and use of cleanrooms would be restraining the growth of healthcare cleanrooms market during the forecast period to a certain extent.

September 2014 $ 5650 selected

Freeze Drying / Lyophilization Equipment Market by Scale (Lab, Pilot, & Industrial), Technology (Rotary, Manifold, & Tray - style) & by Accessories (Loading/Unloading System, Vacuum System, Clean-in-Place System, Control System) - Global Forecast to 2019

Freeze drying is an efficient method for drying various unstable, heat sensitive, aqueous products in various industries. In the healthcare industry, freeze drying is mostly used in pharmaceutical and biotech manufacturing.

September 2014 $ 5650 selected

Animal Antimicrobials and Antibiotics Market by Products (Tetracyclines, Penicillins, Sulfonamides, Aminoglycosides), Animals (Dog, Poultry, Swine), Mode Of Delivery (Premixes, Oral Powders and Solutions, Injections) - Global Forecasts to 2018

The global animal antimicrobials and antibiotics market is valued at $3,340.8 million in 2013 and is estimated to reach $4,143.4 million by 2018. The rising demand for animal protein products in the emerging countries and the increasing trend for companion animal ownership are some of the factors driving the growth of this market.

May 2014 $ 5650 selected

Stem Cell Therapy Market by Treatment Mode (Autologous & Allogeneic), Therapeutic Applications (CNS, CVS, GIT, Wound Healing, Musculoskeletal, Eye, & Immune System) - Regulatory Landscape, Pipeline Analysis & Global Forecasts to 2020

The global stem cell therapy market on the basis of the mode of treatment is segmented into allogeneic and autologous stem cell therapy. The allogeneic stem cell therapy is expected to command the largest share of the stem cell therapy market in 2015, and the allogeneic stem cell therapy segment is expected to grow at the highest CAGR of 40% in the forecast period (2015-2020).

April 2014 $ 5650 selected

Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market – (Pipeline Forecast & Market Forecast in G8 Countries) (2011 – 2020)

The incidence of acute lymphocytic leukemia is high in children from 0 to 14 years than the people aged above 14. It is the most common childhood acute lymphocytic leukemia. However, the acute lymphocytic leukemia may also occur in adults. Acute lymphocytic leukemia distribution depends on age. For instance, 30% of is diagnosed before the age of 5 and 55% of ALL age 15.The acute lymphocytic leukemia market is segmented into two types; namely childhood acute lymphocytic leukemia, and adult acute lymphocytic leukemia. The market was dominated by Hyper-CVAD regimen in 2010. However, in 2020, the market is expected to be equally dominated by Hyper-CVAD and Linker regimen.

December 2013 $ 5650 selected

Leukemia Therapeutics Market (Acute/Chronic Lymphocytic Leukemia & Acute/Chronic Myeloid Leukemia) Pipeline Forecast & Market Forecast in G8 Countries - Global Forecast to 2020

Leukemia is the type of blood cancer and the ninth most common one in males. It accounts for almost 0.0148% of all the men and 0.009% of all the women worldwide. The leukemia market is segmented into four types; namely acute lymphocytic leukemia, chronic lymphocytic leukemia, acute myeloid leukemia, and chronic myeloid leukemia. The market was dominated by chronic myeloid leukemia in 2010. However, in 2020, the market is expected to be equally dominated by acute lymphocytic leukemia and chronic myeloid leukemia.

November 2013 $ 5650 selected

North America Weight Loss /Obesity Management Market – [Meal Replacements, Slimming Centers, Nutrition & Psychological Consultancy, Treadmill, Ellipticals, Strength Training, Gastric Bypass, Intragastric Balloon System, StomaphyX] – Forecasts to 2017

Obesity and weight gain have always been major concerns regarding the health and fitness of individuals; today, it has reached the level of an epidemic. Increasing obesity rate and increasing levels of awareness amongst calorie-conscious consumers in North America have opened new avenues for the weight management industry.

July 2013 $ 5650 selected

Asia-Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, C-13) – Forecast to 2017

The market is broadly classified into two segments, namely, diagnostic and therapeutic; the former dominated with about 80.7% share in 2012.

May 2013 $ 5650 selected

Autologous Stem Cell and Non-Stem Cell Based Therapies Market (2012 – 2017) - (Neurodegenerative, Cardiovascular, Cancer & Autoimmune, Skin and Infectious Diseases)

Autologous cell therapies are new therapeutic intervention where it introduces or uses cells or tissues from the individual, cultured, expanded and re-introduced at the site of the disease of the donor. They are widely promoted as next pillar or advancement in medical care.

October 2012 $ 5650 selected

Chronic Lymphocytic Leukemia Therapeutics Market in G8 Countries (2010 - 2020)

Chronic lymphocytic leukemia is the second most common cancer in adult males and rarely occurs in children. The risk of chronic lymphocytic leukemia is closely associated with age. About 90% of chronic lymphocytic leukemia is diagnosed in middle age. Incidence rate of CLL is high in men and women over 50 years of age. The chronic lymphocytic leukemia market is segmented into two types; namely childhood chronic lymphocytic leukemia and adulthood lymphocytic leukemia. The market was dominated by Campath drug in 2010. However, in 2020, the market is expected to be equally dominated by GA101/RG7159 molecule and Arzerra drug.

December 2011 $ 5650 selected

Prostate Cancer Therapeutics Market (2010-2020) (Opportunity Analysis, Pipeline Assessment and Global Market Forecast)

Prostate cancer is the most frequently diagnosed cancer in men. In terms of loss of life from any disease, prostate cancer ranks eleventh; and it ranks sixth in terms of cancer-related mortality in men. The prostate cancer market has a huge demand for new and novel drugs that address unmet needs such as improved survival time, less toxicity, increased progression free survival, increased effectiveness, and lower cost.

November 2011 $ 5650 selected

Lung Cancer Therapeutics Market (NSCLC & SCLC) - 2010-2020 (Pipeline Assessment and Market Forecast) in G7 countries

Lung cancer is responsible for most of the deaths (due to cancer) across the globe. With just one drug slated to be launched by 2014 – Talactoferrin by Agennix AG, for patients with advanced lung cancer; having failed both chemotherapy and treatments with epidermal growth factor receptor (EFGR) - Tyrosine kinase inhibitor (TKI). Lung cancer is still an area with high unmet need for early diagnosis and limited treatment options in the advanced stages of lung cancer.

November 2011 $ 5650 selected

Global Clinical Trials Market (Key Therapeutic Categories, Country Wise Metrics & Regulatory Approval Framework)

This research report categorizes the Global Clinical Trials Market on the basis of phases, indications, and study design analyzing trends in each. Each section will provide market data, market drivers, trends and opportunities, key players, and competitive outlook. This report will also provide more than 20 company profiles.

September 2011 $ 5650 selected

Global Lung Cancer Surgery Market (Devices & Treatment Outlook) – Trends & Challenges (2010 – 2015)

The lung cancer surgery market is expected to grow at a CAGR of 4.9% during the study period (2010-2015). Thoracotomy is the most widely used surgical procedure for lung cancer treatment accounting for about 74% of all surgical interventions.

June 2011 $ 5650 selected

US Neonatal (Preterm) Infant Care Market (2010-2015)

Preterm infant care forms a significant part of the pediatric healthcare market in U.S as preterm births are on a alarming rise in the nation. Preterm births are one of the leading causes of infant mortality in U.S with 1 in 8 births being preterm. Induced fertility and labor treatments, poor prenatal care, inappropriate maternal age, obesity, smoking are some of the major reasons responsible for increasing incidence of preterm births in the country. Preterm infant care products such as infant care devices, infant formula and drugs face a great demand in United States due to the absolute necessity of such products in sustaining baby lives. The products are indispensable in saving preterm babies because they are biologically immature and require external medical assistance in the form of respiratory, nutritional and thermal control support for survival. Infant care products have helped to increase the survival of preterm babies in the country. The criticality of the products in preterm infant care is driving the market. Furthermore, technology advances in regards to multi function equipments are also propelling the growth of the market.

March 2011 $ 5650 selected

Global Weight Loss & Diet Management Products & Services Market (2010 - 2015)

Obesity and weight gain issues have always been major concerns impacting the health and fitness of the individuals. Increasing levels of awareness amongst the calorie conscious consumers have opened up new avenues and opportunities in this market.

February 2011 $ 5650 selected

Global Anesthesia and Respiratory Devices Market (2010-2015)

The global anesthesia and respiratory devices market is expected to witness moderate growth in the coming five years. Respiratory devices account for the largest share (about 57%) in this market; primarily due to their wide usage among the three consumer segments (healthcare institutions, home healthcare and transport) as compared to anesthesia devices; which have limited usage amongst the end-users.

February 2011 $ 5650 selected

Strategic Analysis & Forecast of US Biopharmaceutical Industry (2009-2016): Impact of Healthcare Reform, Technological Innovation & Market

The U.S. biopharmaceuticals market is expected to increase to $144 billion by 2016. The growth is expected as a result of the launch of new products, approval of new indications for existing therapies and drugs, and increase in population aged 65 years and above. From 2009 to 2016 the U.S. market revenues are forecasted to grow at a compound annual growth rate (CAGR) of 11.2%.

February 2011 $ 5650 selected

Pharma & Healthcare Social Media Marketing Strategies

Increasing number of web users’ world wide (1.8 billion), development and popularity of web based community sites (Twitter, Facebook), tools and information centers (branded & unbranded sponsored communities) are changing approach towards Pharma and healthcare marketing and information sharing. In pharma industry social media has emerged as an effective tool for marketing, consumer engagement, monitoring & analyzing user generated content and building & changing brand perception. Social media is emerging as a strategic shift in organizations communication and operation model. Top pharmaceutical market players have started integrating social media in to their marketing mix. The effective social media marketing strategies that can help generate business exposure, market research data, relationship building and thus can prove as an important initiative to boom sales and overall business in the long term

August 2010 $ 5650 selected

BRIC Diabetes Drugs Market (2010-2015) in Brazil, Russia, India, China

The prevalence of diabetes is increasing globally with the increase in life expectancy and rising incidence of obesity. Brazil’s diabetes drugs market is showing a double digit growth rate; while the Russian insulin market is also expected to witness significant growth with an estimated over 20 million patients in the region requiring diabetes treatment by 2025. India and China have the highest number of diabetics in the world – China alone is expected to have more than 71 million diabetic patients by 2025; and the similarly huge patient-base in India has already attracted a number of pharmaceutical companies such as Eli Lilly and Novo Nordisk. These companies are offering easy-to-use insulin versions to grab the market share in the Indian market for diabetes drugs. Thus, diabetes drugs market in BRIC economies is expected to have significant growth opportunities in the years to come.

April 2010 $ 5650 selected

Opportunity Analysis of H1N1 (swine flu) Vaccination Market

The increase in public awareness and government initiatives, as a consequence of scare from pandemic flu has resulted in the drastic rise in demand for the Influenza Vaccines. This transient boost in demand of seasonal influenza vaccines is an impact of prevailing H1N1 pandemic, due to apprehension and lack of clarity among the general public. The emerging technologies in production are going to give a new face to the market dynamics of this market. The upcoming vaccines and drugs by various players in the market such as Novartis’ Optaflu and ProteinSciences’ FluBlock, along with the emerging technologies in production are going to give a new face to the market dynamics of this market.

November 2009 $ 5650 selected

Autoimmune Treatment Market (2009 - 2014)

The report sizes the market for the diagnosis and therapeutic technologies for the auto immune diseases. It also tracks the advances in the technologies along with the profiles and strategies of the key players in this market. The report highlights the new approaches being pursued in this market.

September 2009 $ 5650 selected

Global Weight Loss and Diet Management Market (2009 - 2014)

Obesity and weight gain issues have always been a major concern impacting the health and fitness of the individuals. Increasing awareness levels among the appearance and calorie conscious consumers has opened up new avenues and opportunities to this market. The rate of new product entry in the weight management segment is significantly high, necessitating industry participants to adopt proactive strategies and keep ahead of competition.

July 2009 $ 5650 selected

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 

Live Chat Support

US : 1-888-600-6441
UK : 44-800-368-9399

Search reports

M&M Custom Research Services provides clients with the information on their business scenario required to stay ahead of competition in today's fast paced business environment.
'Connect With Us

Call us at: 1-888-600-6441
Live Chat Support

Access reports on all high
growth Pharmaceuticals Markets on KnowledgeStore
Request Demo Now